WingerchukDMBanwellBBennettJL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology2015; 85(2): 177–189.
2.
Carnero ContenttiECorrealeJ. Neuromyelitis optica spectrum disorders: From pathophysiology to therapeutic strategies. J Neuroinflammation2021; 18(1): 208.
3.
Carnero ContenttiELópezPACrinitiJ, et al. Frequency of NMOSD misdiagnosis in a cohort from Latin America: Impact and evaluation of different contributors. Mult Scler2023; 29(2): 277–286.
4.
Carnero ContenttiEOkudaDTRojasJI, et al. MRI to differentiate multiple sclerosis, neuromyelitis optica, and myelin oligodendrocyte glycoprotein antibody disease. J Neuroimaging2023; 33(5): 688–702.
5.
RomozziMVollonoCCalabresiP, et al. Partialis continua as a manifestation of aquaporin-4 autoimmunity. Mult Scler2024; 30(13): 1690–1693.
6.
NoviGSbragiaEBenedettiL, et al. Relapsing meningitis and limbic encephalitis in anti-AQP4-Ab associated neuromyelitis optica 2 spectrum disorder. Mult Scler2024; 30(13): 1693–1697.
7.
KunchokAChenJJMcKeonA, et al. Coexistence of myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies in adult and pediatric patients. JAMA Neurol2020; 77(2): 257–259.
8.
XiaoJZhangSQChenX, et al. Comparison of clinical and radiological characteristics in autoimmune GFAP astrocytopathy, MOGAD and AQP4-IgG+ NMOSD mimicking intracranial infection as the initial manifestation. Mult Scler Relat Disord2022; 66: 104057.
